TD Cowen Maintains Buy on Gilead Sciences, Raises Price Target to $175
Benzinga Newsdesk 22 hours ago
Analyst RatingsNewsPrice TargetHot
TD Cowen analyst Tyler Van Buren maintains Gilead Sciences (NASDAQ:GILD) with a Buy and raises the price target from $160 to $175.
TD Cowen analyst Tyler Van Buren maintains Gilead Sciences (NASDAQ:GILD) with a Buy and raises the price target from $160 to $175.